Objective: To investigate the cholesterol-lowering effects of a low-fat cheese enriched with plant stanol esters in mildly hypercholesterolaemic subjects, as part of their normal diet. Design: A randomized double-blind parallel-group study. Setting: Valio Ltd, Helsinki. Subjects: Sixty-seven mildly hypercholesterolaemic volunteers (24 men, 43 women) participated in the study, which all of them completed. Interventions: The subjects were randomly assigned to the plant stanol ester group or the control group. During the 5-week intervention, the subjects in the stanol group consumed a cheese enriched with 2 g of plant stanols per day, and the subjects in the control group, a control cheese with no plant stanols. Results: In the stanol ester group, as compared to the control group, both serum total and low-density lipoprotein (LDL) cholesterol decreased significantly, that is, by 5.8% (À0.32 mmol/l, 95% CI À0.50 to À0.15 mmol/l, Po0.001) and 10.3% (À0.36 mmol/l, 95% CI À0.53 to À0.18 mmol/l, Po0.001), respectively. There were no significant changes in high-density lipoprotein cholesterol (HDL), triglycerides or apolipoprotein B concentrations between the groups. Conclusion: Cheese enriched with 2 g of plant stanol in the form of fatty acid esters decreases serum total and LDL cholesterol significantly.
Introduction
Hypercholesterolaemia is one of the major risk factors for coronary heart disease (Stamler et al., 1999 (Stamler et al., , 2000 , and considerable efforts have focused on different methods of lowering elevated serum cholesterol levels. Various drugs are used for patients with severe hypercholesterolaemia, whereas for those with mild or moderate hypercholesterolaemia, dietary therapy is used to lower serum cholesterol levels. Non-pharmacological treatment is also considered to be an important alternative for patients with mild or moderate hypercholesterolaemia.
One interesting alternative among non-pharmacological treatments is the use of plant sterols. Plant sterols are a group of compounds very similar in structure to cholesterol (Ikeda et al., 1989) . The most common plant sterols are b-sitosterol, campesterol and stigmasterol (Pollak, 1985) . The saturation of the double bonds of plant sterols results in the formation of plant stanols. Plant stanols reduce the absorption of both dietary and biliary cholesterol by displacing cholesterol from the micellar phase (Ikeda et al., 1989) . When the absorption of cholesterol decreases, the synthesis of cholesterol in the liver increases, thus enhancing cholesterol turnover (Gylling et al., 1999) . Several studies have shown that 2-3 g of plant stanols per day reduces total and low-density lipoprotein cholesterol (LDL-C) concentrations without changing highdensity lipoprotein cholesterol (HDL-C) and triglyceride (TG) concentrations Hallikainen et al., 2000a; Nestel et al., 2001; Mensink et al., 2002) .
In most studies, the cholesterol-lowering effect of plant stanol ester has been studied with plant stanols incorporated in an ordinary or low-fat margarine (Gylling and Miettinen, 1994; Gylling et al., 1995 Gylling et al., , 1997 Miettinen et al., 1995; Hallikainen and Uusitupa, 1999; Hallikainen et al., 2000a Hallikainen et al., , b, 2002 Tammi et al., 2002) or mayonnaise (Vanhanen et al., 1993; Miettinen and Vanhanen, 1994) . Mensink et al. (2002) also reported that a yoghurt enriched with 3 g/day of plant stanols reduced LDL cholesterol significantly. The effects of dairy products other than yoghurt, enriched with plant stanol esters, have not so far been published. In the West, milk products have an important role in the diet.
The purpose of this study was to investigate the effect of a low-fat hard cheese enriched with plant stanol ester on serum cholesterol levels in mildly hypercholesterolaemic subjects, as part of their normal diet.
Subjects and methods

Subjects
Sixty-seven mildly hypercholesterolaemic subjects applied for the study. The inclusion criteria were serum total cholesterol concentration of between 5.0 and 6.5 mmol/l and total TG concentration below 3.0 mmol/l at screening (week À1), age 25-65 years, no lipid-lowering medication and no unstable coronary artery diseases. Subjects with diabetes mellitus, malignant diseases, alcohol abuse (over four portions per day) or milk allergy, or who were pregnant were also excluded. Subjects were not allowed to consume any products enriched with plant stanol ester or plant sterol during the study and for 3 weeks before the study. The inclusion criteria were checked during the screening visit before randomization. Sixty-seven subjects (24 men, 43 women) fulfilled these criteria and were randomly assigned to the plant stanol ester group (n ¼ 33) or to the control group (n ¼ 34). At the beginning of the study, their mean age was 43.379.5 years (mean7s.d.). Two subjects were taking antiasthma medication, one subject, postmenopausal estrogen therapy, four had thyroxin therapy for hypothyroidism and six, blood pressure-lowering medicine. Nine subjects were smokers. The subjects gave their written consent to the study, and the study protocol was approved by the Ethics Committee at the Department of Medicine, Helsinki University Central Hospital.
Study design and diet
This study was a randomized, double-blind, parallel-group study. The sample size calculation was based on previous studies on the effect of stanol esters on cholesterol (the risk level is 5% and the power is 80% when the expected difference between the groups is 6.5% in total cholesterol (TC) and 11% in LDL-C). The subjects visited the health centre five times: at the beginning of the run-in period (week -1) and the treatment period (week 0), and during the treatment at weeks 3, 4 and 5.
After the run-in period, the subjects were randomly assigned to one of the treatment groups: the subjects in the stanol group ingested 50 g of low-fat cheese enriched with plant stanol ester per day, and the subjects in the control group ingested a control cheese without plant stanols. During the 5-week treatment period, the subjects consumed the daily dose of the cheese product either once a day with lunch or in two separate portions with their two main meals. The control and experimental cheeses were similar in colour and taste. The nutrient content of the control cheese (1 dose ¼ 50 g) was as follows: energy 600 kJ, carbohydrates 0 g, protein 17 g, fat 8.5 g, saturated fat 4.5 g. The stanol cheese was similar in every way to the control cheese, except that it also contained 3.4 g of plant stanol esters per dose. Two grams of plant stanol mixture containing sitostanol and campestanol was transesterified with 1.4 g of rapeseed oil fatty acids (Raisio group, Raisio, Finland) and the plant stanol esters were then mixed with the study cheese.
The subjects were instructed to maintain their normal dietary habits and lifestyle. Weight was measured at each visit using a digital scale. Dietary intake was assessed by means of a food frequency questionnaire during the first and last study visits. Another structured questionnaire collected information on smoking habits and physical activities during the study. Information on the occurrence and severity of gastrointestinal symptoms and other adverse effects was collected by means of a structured questionnaire during the two last study visits. In addition, at each visit, the subjects were asked about current medication and any changes in medication.
Laboratory measurements
At each study visit, blood samples were taken after a 12-h overnight fast. The measurements were taken at United Laboratories Ltd, Helsinki, Finland. Serum TC, HDL-C and TG concentrations were measured by an enzymatic method. LDL-C was calculated according to Friedewald's equation (Friedewald et al., 1972) . This method is generally accepted, and is accurate when total TG concentration is below 4.0 mmol/l, as was the case with our subjects. Apolipoprotein B (apo B) was determined at the second and the last study visits by an immunoturbiometric method. Routine laboratory measurements and safety parameters (gamma-glutamyltransferase, creatinine, glucose, uric acid) were measured at Effects of cheese enriched with plant stanols on serum lipids T Jauhiainen et al the beginning and at the end of the study to make sure that the subjects maintained their normal health status.
Statistical analyses
Baseline cholesterol levels for TC, HDL, LDL and TG were defined as the mean of the values measured at weeks 1 and 0.
The mean values of the serum lipid measurements after 4 weeks and 5 weeks of treatment were used to estimate the cholesterol level at the end of the intervention. As the primary analysis, the changes from baseline to the end of the treatment period were calculated for both groups and were compared between the groups by an independent samples t-test. The results are given as means and s.e.m.s. The treatment differences (stanol vs control) are given as means with 95% confidence intervals. As the secondary analysis, the changes from baseline to weeks 3, 4 and 5 were analysed separately using the independent samples t-test. All statistical analyses were performed with the SPSS statistics program (Version 12.0; SPSS Inc., Chicago, IL, USA).
Results
General
All 24 men and 43 women completed the study. The mean body weight at the beginning of the study was 74.0 kg in the stanol group and 76.3 kg in the control group. Weight decreased by 0.5 kg during the study in both groups. Two subjects took up smoking during the study. There were no significant changes in the dietary intake or physical activity in either of the groups (data not shown).
Compliance with the cheese was excellent: 99% of the cheese was eaten. During the study, 14 subjects in the stanol group and 21 subjects in the control group reported that they suffered adverse effects such as headaches, tiredness, flatulence, diarrhoea and constipation. Most of these symptoms were mild and occurred only occasionally, but one subject in the control group reported that constipation and abdominal discomfort were very disturbing during the first 3 weeks of the study. There were no significant differences in the changes in routine safety parameters between the groups (data not shown). Table 1 shows TC, LDL-C, HDL-C, TG and apo B at baseline and at the end of the study in the stanol (n ¼ 33) and the control (n ¼ 34) groups. Compared to the control group, serum TC decreased by 5.8% (95% CI À8.8 to À2.8%; Po0.001) and LDL-C by 10.3% (95% CI À14.9 to À5.7%; Po0.001) in the stanol group. The differences between the stanol group and the control group in TC and LDL-C were statistically significant. The maximal difference in TC and LDL-C (Figure 1 ) between the groups had already been reached after only 3 weeks of treatment. The difference between the groups remained stable from then on, a result confirmed by analysis of variance for repeated measures (weeks 3, 4 and 5; time effect P ¼ 0.986 for TC and P ¼ 0.317 for LDL-C). The cholesterol-lowering effect of stanol treatment was similar in both men and women (data not shown). There were no significant differences in HDL-C and TG between the groups (Table 1) .
Serum lipids and apolipoprotein B
There were no statistically significant differences between the effects on apo B of the stanol ester and control cheeses (Table 1) . However, apo B decreased by 11.4% in the stanol group and by 6.7% in the control group. Compared to the control group, apo B decreased by 4.7% (95% CI À10.0 to 0.6; P ¼ 0.080) in the stanol group.
Discussion
This randomized double-blind study showed that a low-fat hard cheese enriched with plant stanol ester lowered serum TC concentrations by nearly 6% and LDL-C concentrations by 10%. This result is similar to those of earlier studies, in which plant stanol esters (2-3 g/day of plant stanols) have reduced LDL-C by 9-15% (Vanhanen et al., 1993; Gylling and Miettinen, 1994; Gylling et al., 1995 Gylling et al., , 1997 Gylling et al., , 1999 Miettinen et al., 1995; Hallikainen and Uusitupa, 1999; Hallikainen et al., 2000a; Mensink et al., 2002) . Our result also confirms the fact that plant stanol ester does not affect serum HDL-C or TG.
In the present study, the treatment period was 5 weeks, which was estimated to be long enough for a significant reduction of serum cholesterol levels. In earlier clinical studies, the ingestion of plant stanols for 4-7 weeks has reduced serum cholesterol levels significantly (Gylling and Miettinen, 1994; Gylling et al., 1995 Gylling et al., , 1997 Hallikainen et al., 2000a, b; Mensink et al., 2002) . It has also been reported that the full cholesterol-lowering effect can be reached within 1-2 weeks with the use of plant stanol (Hallikainen et al., 2002; Mensink et al., 2002) . In our study, the maximal reduction in cholesterol levels was also reached by the first measurement, that is, after 3 weeks of treatment, and the difference between the groups remained stable thereafter. As was seen in earlier studies (Hallikainen et al., 2000a; Tammi et al., 2002) , the cholesterol-lowering effect of plant stanol esters did not differ between the genders.
Because the plant stanols were transesterified with rapeseed oil fatty acids, the amount of fat was slightly higher in the stanol cheese than in the control cheese. However, this small quantity of rapeseed oil (1.4 g/day) cannot have been sufficient to cause the cholesterol-lowering effect observed after ingestion of the stanol cheese. Thus one can with confidence claim that the reduction in serum lipids in the stanol group was almost certainly owing to the plant stanols. The daily intake of plant stanol was 2 g, which was, on the basis of the earlier studies (Vanhanen et al., 1993; Gylling and Miettinen, 1994; Gylling et al., 1995 Gylling et al., , 1997 Gylling et al., , 1999 Miettinen et al., 1995; Hallikainen and Uusitupa, 1999; Hallikainen et al., 2000a; Mensink et al., 2002) , estimated to be adequate.The daily dose of the cheese product was taken in one or two portions with main meals. It has been reported that plant stanols, either consumed once a day or divided between the meals, resulted in a similar decrease in serum lipids . It seems unlikely, therefore, that the cholesterol-lowering effect of this stanol ester cheese would have been stronger if the cheese had been divided between the meals. In contrast to most other studies for testing the cholesterollowering effect of a margarine enriched with plant stanols (Hallikainen et al., 2000a (Hallikainen et al., , b, 2002 Tammi et al., 2002) , we investigated the effect of a dairy product enriched with these stanols. In another study, which tested the cholesterol-lowering effect of a dairy product, a low-fat yoghurt enriched with plant stanols (3 g/day) reduced serum TC and LDL-C by 8.7 and 13.7%, respectively (Mensink et al., 2002) . In our study, plant stanol esters were ingested in a cheese with a higher fat content (17%). It seems that the cholesterol-lowering effect of plant stanols is very similar regardless of the food matrix in which it is ingested.
Although an increased concentration of LDL-C is the main risk factor for coronary heart disease, the constituents of LDL-C, apolipoproteins, may also play an important role in atherosclerosis (Homma, 2004) . In earlier studies, serum apo B concentration has decreased significantly after the use of plant stanols (Gylling and Miettinen, 1994; Hallikainen et al., 2000b; Homma et al., Weeks LDL cholesterol (mmol/l) 2. Baseline cholesterol and apo B levels were defined as the mean of the values measured at weeks -1 and 0. The levels at the end of the study were calculated from the values measured at weeks 4 and 5. The changes were compared by the independent samples t-test. *Significant difference between the stanol and control treatments.
2003), and these decreases have been parallel to those of serum LDL-C concentrations (Hallikainen et al., 2000a; Homma et al., 2003) , possibly implying that plant stanols reduce large, less dense LDL particles and small, dense LDL particles equally (Homma et al., 2003) . Small, dense LDL particles are rich in apo B and thus are considered to be extremely atherogenic (Homma, 2004) . Compared to the control treatment, we found no statistically significant changes in serum apo B concentration after ingestion of plant stanol esters. However, serum apo B decreased in both groups, and the reduction in apo B concentrations was parallel to the reduction of serum LDL-C concentrations. It seems, therefore, that the cheese enriched with stanol ester had beneficial effects on both serum lipid and apo B concentrations.
In the present study, mild side effects such as gastrointestinal symptoms were fairly common. These symptoms were similar to those found in earlier studies (Hallikainen et al., 2000b; Neil et al., 2001 ) and occurred occasionally in both groups. As in earlier studies (Gylling et al., , 1999 Miettinen et al., 1995; Mensink et al., 2002) , no serious adverse effects were reported. In addition, we found no changes in the safety parameters.
In conclusion, a cheese enriched with plant stanol ester reduces serum total cholesterol and LDL cholesterol levels to the same extent as oil-based products, and also has a beneficial effect on serum apo B concentration. Thus, a cheese enriched with plant stanol ester can be recommended for hypercholesterolaemic subjects despite its high content of saturated fat and cholesterol.
